Analyst Ratings for CVS Health Corp. (CVS)

Updated: 2017-07-28

Analysts covering CVS Health Corp. (NYSE:CVS) have given it a consensus rating of Overweight. CVS had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 16 analysts, 1 gave an overweight rating, 8 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Several price targets were given for CVS by the analysts covering the stock. The highest price target was 109, which equates to a potential upside of 38.11 percent. The most pessimistic price target was 77, implying potential capital losses of -2.43 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. That number becomes -0.76 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 0.17 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. Over the same time period, 3 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.

The growth rate of CVS's earnings is estimated by analysts to be 23.24 percent. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, because people typically see that as an indicator of higher growth relative to stock price. People often look for the PEG ratio to be under 1, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of CVS is 0.71.

In the last 52-weeks, CVS has achieved a high of 98.66 and a low of 69.30. Currently the stock is 13.88 percent higher than its low, and below the high by 20.01 percent. CVS has a P/E ratio of 16.44. Investors typically compare the P/E ratio to a company's peers in the industry. The CVS value stock report compares CVS to some of its peers using value stock charts. The stock has a market capitalization of $79.76 billion. CVS's next earnings release will be on 0000-00-00, which is days away.